In a filing, Vertex Pharmaceuticals, Inc revealed its EVP, Chief Scientific Officer ALTSHULER DAVID unloaded Company’s shares for reported $7178.0 on Nov 15 ’24. In the deal valued at $478.56 per share,15 shares were sold. As a result of this transaction, ALTSHULER DAVID now holds 25,813 shares worth roughly $12.08 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ALTSHULER DAVID bought 15 shares, generating $7,178 in total proceeds.
Before that, WAGNER CHARLES F JR sold 3,000 shares. Vertex Pharmaceuticals, Inc shares valued at $1,554,810 were divested by the EVP & Chief Financial Officer at a price of $518.27 per share. As a result of the transaction, WAGNER CHARLES F JR now holds 44,137 shares, worth roughly $20.66 million.
Jefferies upgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to a Buy from a a Hold in a research note published on December 09, 2024; the price target was increased to $550 from $500. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid November with a ‘”a Buy”‘ rating. Scotiabank began covering VRTX with “Sector perform” recommendation on October 16, 2024.
Price Performance Review of VRTX
On Monday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 0.94% to $468.09. Over the last five days, the stock has lost -1.24%. Vertex Pharmaceuticals, Inc shares have risen nearly 15.04% since the year began. Nevertheless, the stocks have risen 15.12% over the past one year. While a 52-week high of $519.88 was reached on 11/08/24, a 52-week low of $391.01 was recorded on 04/18/24. SMA at 50 days reached $473.59, while 200 days put it at $457.40.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 463.45, which if violated will result in even more drops to 458.81. On the upside, there is a resistance level at 471.40. A further resistance level may holdings at 474.72. The Relative Strength Index (RSI) on the 14-day chart is 49.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 31.63%. Stochastics %K at 58.42% indicates the stock is a holding.
How much short interest is there in Vertex Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc stocks on 2024-11-29, dropping by -0.83 million shares to a total of 3.67 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 4.5 million shares. There was a decline of -22.7%, which implies that there is a negative sentiment for the stock.
